Ameritas Investment Company’s AstraZeneca AZN Stock Holding History

Ameritas Investment Company’s Portfolio AZN Stock Details AZN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	$636K	Buy	+5,299	New	+$617K	0.03%	361
2021 Q2	–	Sell	-3,331	Closed	-$331K	–	828
2021 Q1	$331K	Buy	+3,331	New	+$335K	0.03%	439
2020 Q2	–	Sell	-528	Closed	-$47K	–	429
2020 Q1	$47K	Buy	528 +397	+303%	+$37.4K	0.01%	718
2019 Q4	$13K	Sell	131 -56	-30%	-$5.27K	﹤0.01%	729
2019 Q3	$17K	Buy	+187	New	+$16.2K	﹤0.01%	970
2019 Q2	–	Sell	-33	Closed	-$3K	–	278
2019 Q1	$3K	Sell	33 -1,526	-98%	-$120K	﹤0.01%	803
2018 Q4	$118K	Buy	+1,559	New	+$122K	0.03%	384

Other funds holding AZN

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

GQG Partners Ft. Lauderdale, Florida $63.1B AUM 23.07% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Ameritas Investment Company's AZN Position: Q3 2021 in Review

Ameritas Investment Company opened a new position in AstraZeneca (AZN) in Q3 2021: 5,299 shares worth $636K. The stake represents 0.03% of the portfolio and ranks #361 among its holdings. This is a return to the name: Ameritas Investment Company previously reported a position in AZN as recently as Q1 2021.

Ameritas Investment Company first reported a position in AZN in Q4 2018 and has held it in 7 quarters since. 906 funds tracked by Wall St. Rank hold AZN as of Q3 2021.

Ameritas Investment Company held 5,299 shares of AstraZeneca worth $636K as of Q3 2021.
AstraZeneca was a new Ameritas Investment Company position in Q3 2021.
AstraZeneca made up 0.03% of Ameritas Investment Company's portfolio in Q3 2021, its #361 holding.
Ameritas Investment Company first reported a position in AstraZeneca in Q4 2018 and has held it in 7 quarters since.
906 funds tracked by Wall St. Rank held AstraZeneca as of Q3 2021.

Based on Ameritas Investment Company's 13F filing for Q3 2021, filed 12 Nov 2021.